首页 | 本学科首页   官方微博 | 高级检索  
     

国外药品效益风险评价研究进展
引用本文:卢玉美,张明慧,武志昂. 国外药品效益风险评价研究进展[J]. 中国药物警戒, 2013, 0(8): 473-477
作者姓名:卢玉美  张明慧  武志昂
作者单位:沈阳药科大学工商管理学院,辽宁沈阳110016
摘    要:
药品的效益风险评价是保证药品安全性的重要手段,因此建立科学、综合、统一的评价方法和框架尤为重要。本文从监管机构、行业组织以及企业3个角度,分别阐述国外药品效益风险评价的热点问题与研究进展。同时结合我国研究现状,对国内药品效益风险评价提出建议。

关 键 词:药品  效益  风险  评价

Overview of Drug Benefit-Risk Assessment Research Progress
LU Yu-mei,ZHANG Ming-hui,WU Zhi-ang. Overview of Drug Benefit-Risk Assessment Research Progress[J]. Chinese JOurnal of Pharmacovigilance, 2013, 0(8): 473-477
Authors:LU Yu-mei  ZHANG Ming-hui  WU Zhi-ang
Affiliation:(Business School of Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China)
Abstract:
Benefit-risk assessment is an important means of ensuring drug safety, so it is particularly important to establish scientific, comprehensive and unified evaluation method and framework. In order to understand the foreign research situation of drug benefit-risk assessment, this article describes the hot topics and research progress among agencies, industry organizations, as well as enterprise, and further research areas. Moreover, based on the present situation of our drugs benefit-risk assessment. regulatory summerises the challenges and prospects of current country, the article provides reference for domestic
Keywords:drugs  benefit  risk  assessment
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号